Zentalis Pharmaceuticals, Inc. (ZNTL)
3.60
-0.16
(-4.26%)
USD |
NASDAQ |
Sep 01, 09:59
Zentalis Pharmaceuticals Cash and Short Term Investments (Quarterly) : 174.61M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 174.61M |
| March 31, 2026 | 211.76M |
| December 31, 2025 | 245.89M |
| September 30, 2025 | 280.70M |
| June 30, 2025 | 303.43M |
| March 31, 2025 | 332.45M |
| December 31, 2024 | 371.08M |
| September 30, 2024 | 391.25M |
| June 30, 2024 | 426.38M |
| March 31, 2024 | 488.98M |
| December 31, 2023 | 482.92M |
| September 30, 2023 | 516.64M |
| June 30, 2023 | 552.99M |
| March 31, 2023 | 392.52M |
| Date | Value |
|---|---|
| December 31, 2022 | 437.37M |
| September 30, 2022 | 421.73M |
| June 30, 2022 | 455.22M |
| March 31, 2022 | 289.61M |
| December 31, 2021 | 340.13M |
| September 30, 2021 | 367.03M |
| June 30, 2021 | 251.14M |
| March 31, 2021 | 298.38M |
| December 31, 2020 | 338.50M |
| September 30, 2020 | 367.44M |
| June 30, 2020 | 233.19M |
| March 31, 2020 | 63.65M |
| December 31, 2019 | 67.25M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 143.84M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |